Global Pediatric Preventable Vaccine Market Research Report 2026(Status and Outlook)

May 2026 | 156 pages | ID: G5FEDA64868CEN
Bosson Research

Abstracts

Pediatric preventable vaccines are immunizations designed to prevent common infectious diseases in children. These vaccines target illnesses that children are particularly susceptible to, such as measles, pertussis, diphtheria, polio, and influenza, significantly reducing the risk of disease, complications, and mortality. They form a critical component of public health strategies by fostering herd immunity to protect individuals and the broader community.

The global Pediatric Preventable Vaccine market size was estimated at USD 22340.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.10% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Pediatric Preventable Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Pediatric Preventable Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pediatric Preventable Vaccine market.

Global Pediatric Preventable Vaccine Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Pfizer Inc.
• Merck & Co., Inc.
• GlaxoSmithKline plc (GSK)
• Sanofi Pasteur
• Moderna, Inc.
• Serum Institute of India Pvt.
• Bharat Biotech International
• CSL Limited (Seqirus)
• Emergent BioSolutions Inc.
• Daiichi Sankyo Company
• Novavax, Inc.
• Sinovac Biotech
• Sinopharm Group Co.,
• Johnson & Johnson (Janssen)
• AstraZeneca plc

Market Segmentation (by Type)

• Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Mrna Vaccines
• Viral Vector Vaccines

Market Segmentation (by Application)

• Bacterial Diseases
• Virus Diseases

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pediatric Preventable Vaccine Market

Overview of the regional outlook of the Pediatric Preventable Vaccine Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pediatric Preventable Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Pediatric Preventable Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pediatric Preventable Vaccine
1.2 Key Market Segments
  1.2.1 Pediatric Preventable Vaccine Segment by Type
  1.2.2 Pediatric Preventable Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PEDIATRIC PREVENTABLE VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pediatric Preventable Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Pediatric Preventable Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PEDIATRIC PREVENTABLE VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Pediatric Preventable Vaccine Product Life Cycle
3.3 Global Pediatric Preventable Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pediatric Preventable Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pediatric Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pediatric Preventable Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Pediatric Preventable Vaccine Market Competitive Situation and Trends
  3.8.1 Pediatric Preventable Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Pediatric Preventable Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PEDIATRIC PREVENTABLE VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Pediatric Preventable Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PEDIATRIC PREVENTABLE VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Pediatric Preventable Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Pediatric Preventable Vaccine Market
5.7 ESG Ratings of Leading Companies

6 PEDIATRIC PREVENTABLE VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pediatric Preventable Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pediatric Preventable Vaccine Market Size by Type (2020-2025)
6.4 Global Pediatric Preventable Vaccine Price by Type (2020-2025)

7 PEDIATRIC PREVENTABLE VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pediatric Preventable Vaccine Market Sales by Application (2020-2025)
7.3 Global Pediatric Preventable Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pediatric Preventable Vaccine Sales Growth Rate by Application (2020-2025)

8 PEDIATRIC PREVENTABLE VACCINE MARKET SALES BY REGION

8.1 Global Pediatric Preventable Vaccine Sales by Region
  8.1.1 Global Pediatric Preventable Vaccine Sales by Region
  8.1.2 Global Pediatric Preventable Vaccine Sales Market Share by Region
8.2 Global Pediatric Preventable Vaccine Market Size by Region
  8.2.1 Global Pediatric Preventable Vaccine Market Size by Region
  8.2.2 Global Pediatric Preventable Vaccine Market Size by Region
8.3 North America
  8.3.1 North America Pediatric Preventable Vaccine Sales by Country
  8.3.2 North America Pediatric Preventable Vaccine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Pediatric Preventable Vaccine Sales by Country
  8.4.2 Europe Pediatric Preventable Vaccine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Pediatric Preventable Vaccine Sales by Region
  8.5.2 Asia Pacific Pediatric Preventable Vaccine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Pediatric Preventable Vaccine Sales by Country
  8.6.2 South America Pediatric Preventable Vaccine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Pediatric Preventable Vaccine Sales by Region
  8.7.2 Middle East and Africa Pediatric Preventable Vaccine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PEDIATRIC PREVENTABLE VACCINE MARKET PRODUCTION BY REGION

9.1 Global Production of Pediatric Preventable Vaccine by Region(2020-2025)
9.2 Global Pediatric Preventable Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pediatric Preventable Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pediatric Preventable Vaccine Production
  9.4.1 North America Pediatric Preventable Vaccine Production Growth Rate (2020-2025)
  9.4.2 North America Pediatric Preventable Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pediatric Preventable Vaccine Production
  9.5.1 Europe Pediatric Preventable Vaccine Production Growth Rate (2020-2025)
  9.5.2 Europe Pediatric Preventable Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pediatric Preventable Vaccine Production (2020-2025)
  9.6.1 Japan Pediatric Preventable Vaccine Production Growth Rate (2020-2025)
  9.6.2 Japan Pediatric Preventable Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pediatric Preventable Vaccine Production (2020-2025)
  9.7.1 China Pediatric Preventable Vaccine Production Growth Rate (2020-2025)
  9.7.2 China Pediatric Preventable Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Pfizer Inc.
  10.1.1 Pfizer Inc. Basic Information
  10.1.2 Pfizer Inc. Pediatric Preventable Vaccine Product Overview
  10.1.3 Pfizer Inc. Pediatric Preventable Vaccine Product Market Performance
  10.1.4 Pfizer Inc. Business Overview
  10.1.5 Pfizer Inc. SWOT Analysis
  10.1.6 Pfizer Inc. Recent Developments
10.2 Merck and Co., Inc.
  10.2.1 Merck and Co., Inc. Basic Information
  10.2.2 Merck and Co., Inc. Pediatric Preventable Vaccine Product Overview
  10.2.3 Merck and Co., Inc. Pediatric Preventable Vaccine Product Market Performance
  10.2.4 Merck and Co., Inc. Business Overview
  10.2.5 Merck and Co., Inc. SWOT Analysis
  10.2.6 Merck and Co., Inc. Recent Developments
10.3 GlaxoSmithKline plc (GSK)
  10.3.1 GlaxoSmithKline plc (GSK) Basic Information
  10.3.2 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Overview
  10.3.3 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Market Performance
  10.3.4 GlaxoSmithKline plc (GSK) Business Overview
  10.3.5 GlaxoSmithKline plc (GSK) SWOT Analysis
  10.3.6 GlaxoSmithKline plc (GSK) Recent Developments
10.4 Sanofi Pasteur
  10.4.1 Sanofi Pasteur Basic Information
  10.4.2 Sanofi Pasteur Pediatric Preventable Vaccine Product Overview
  10.4.3 Sanofi Pasteur Pediatric Preventable Vaccine Product Market Performance
  10.4.4 Sanofi Pasteur Business Overview
  10.4.5 Sanofi Pasteur Recent Developments
10.5 Moderna, Inc.
  10.5.1 Moderna, Inc. Basic Information
  10.5.2 Moderna, Inc. Pediatric Preventable Vaccine Product Overview
  10.5.3 Moderna, Inc. Pediatric Preventable Vaccine Product Market Performance
  10.5.4 Moderna, Inc. Business Overview
  10.5.5 Moderna, Inc. Recent Developments
10.6 Serum Institute of India Pvt.
  10.6.1 Serum Institute of India Pvt. Basic Information
  10.6.2 Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Overview
  10.6.3 Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Market Performance
  10.6.4 Serum Institute of India Pvt. Business Overview
  10.6.5 Serum Institute of India Pvt. Recent Developments
10.7 Bharat Biotech International
  10.7.1 Bharat Biotech International Basic Information
  10.7.2 Bharat Biotech International Pediatric Preventable Vaccine Product Overview
  10.7.3 Bharat Biotech International Pediatric Preventable Vaccine Product Market Performance
  10.7.4 Bharat Biotech International Business Overview
  10.7.5 Bharat Biotech International Recent Developments
10.8 CSL Limited (Seqirus)
  10.8.1 CSL Limited (Seqirus) Basic Information
  10.8.2 CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Overview
  10.8.3 CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Market Performance
  10.8.4 CSL Limited (Seqirus) Business Overview
  10.8.5 CSL Limited (Seqirus) Recent Developments
10.9 Emergent BioSolutions Inc.
  10.9.1 Emergent BioSolutions Inc. Basic Information
  10.9.2 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Overview
  10.9.3 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Market Performance
  10.9.4 Emergent BioSolutions Inc. Business Overview
  10.9.5 Emergent BioSolutions Inc. Recent Developments
10.10 Daiichi Sankyo Company
  10.10.1 Daiichi Sankyo Company Basic Information
  10.10.2 Daiichi Sankyo Company Pediatric Preventable Vaccine Product Overview
  10.10.3 Daiichi Sankyo Company Pediatric Preventable Vaccine Product Market Performance
  10.10.4 Daiichi Sankyo Company Business Overview
  10.10.5 Daiichi Sankyo Company Recent Developments
10.11 Novavax, Inc.
  10.11.1 Novavax, Inc. Basic Information
  10.11.2 Novavax, Inc. Pediatric Preventable Vaccine Product Overview
  10.11.3 Novavax, Inc. Pediatric Preventable Vaccine Product Market Performance
  10.11.4 Novavax, Inc. Business Overview
  10.11.5 Novavax, Inc. Recent Developments
10.12 Sinovac Biotech
  10.12.1 Sinovac Biotech Basic Information
  10.12.2 Sinovac Biotech Pediatric Preventable Vaccine Product Overview
  10.12.3 Sinovac Biotech Pediatric Preventable Vaccine Product Market Performance
  10.12.4 Sinovac Biotech Business Overview
  10.12.5 Sinovac Biotech Recent Developments
10.13 Sinopharm Group Co.,
  10.13.1 Sinopharm Group Co., Basic Information
  10.13.2 Sinopharm Group Co., Pediatric Preventable Vaccine Product Overview
  10.13.3 Sinopharm Group Co., Pediatric Preventable Vaccine Product Market Performance
  10.13.4 Sinopharm Group Co., Business Overview
  10.13.5 Sinopharm Group Co., Recent Developments
10.14 Johnson and Johnson (Janssen)
  10.14.1 Johnson and Johnson (Janssen) Basic Information
  10.14.2 Johnson and Johnson (Janssen) Pediatric Preventable Vaccine Product Overview
  10.14.3 Johnson and Johnson (Janssen) Pediatric Preventable Vaccine Product Market Performance
  10.14.4 Johnson and Johnson (Janssen) Business Overview
  10.14.5 Johnson and Johnson (Janssen) Recent Developments
10.15 AstraZeneca plc
  10.15.1 AstraZeneca plc Basic Information
  10.15.2 AstraZeneca plc Pediatric Preventable Vaccine Product Overview
  10.15.3 AstraZeneca plc Pediatric Preventable Vaccine Product Market Performance
  10.15.4 AstraZeneca plc Business Overview
  10.15.5 AstraZeneca plc Recent Developments

11 PEDIATRIC PREVENTABLE VACCINE MARKET FORECAST BY REGION

11.1 Global Pediatric Preventable Vaccine Market Size Forecast
11.2 Global Pediatric Preventable Vaccine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Pediatric Preventable Vaccine Market Size Forecast by Country
  11.2.3 Asia Pacific Pediatric Preventable Vaccine Market Size Forecast by Region
  11.2.4 South America Pediatric Preventable Vaccine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Pediatric Preventable Vaccine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Pediatric Preventable Vaccine Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Pediatric Preventable Vaccine by Type (2026-2035)
  12.1.2 Global Pediatric Preventable Vaccine Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Pediatric Preventable Vaccine by Type (2026-2035)
12.2 Global Pediatric Preventable Vaccine Market Forecast by Application (2026-2035)
  12.2.1 Global Pediatric Preventable Vaccine Sales (K MT) Forecast by Application
  12.2.2 Global Pediatric Preventable Vaccine Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pediatric Preventable Vaccine Market Size by Type (M USD)
Table 4. Global Pediatric Preventable Vaccine Market Size by Application
Table 5. Pediatric Preventable Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Pediatric Preventable Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pediatric Preventable Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Preventable Vaccine as of 2025)
Table 11. Global Market Pediatric Preventable Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Pediatric Preventable Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pediatric Preventable Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pediatric Preventable Vaccine Sales by Type (K MT)
Table 27. Global Pediatric Preventable Vaccine Market Size by Type (M USD)
Table 28. Global Pediatric Preventable Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Pediatric Preventable Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Pediatric Preventable Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Pediatric Preventable Vaccine Market Share by Type (2020-2025)
Table 32. Global Pediatric Preventable Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Pediatric Preventable Vaccine Sales (K MT) by Application
Table 34. Global Pediatric Preventable Vaccine Market Size by Application
Table 35. Global Pediatric Preventable Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Pediatric Preventable Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Pediatric Preventable Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pediatric Preventable Vaccine Market Share by Application (2020-2025)
Table 39. Global Pediatric Preventable Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Pediatric Preventable Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Pediatric Preventable Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Pediatric Preventable Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pediatric Preventable Vaccine Market Size by Region (2020-2025)
Table 44. North America Pediatric Preventable Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Pediatric Preventable Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pediatric Preventable Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pediatric Preventable Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pediatric Preventable Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pediatric Preventable Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pediatric Preventable Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Pediatric Preventable Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pediatric Preventable Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pediatric Preventable Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pediatric Preventable Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Pediatric Preventable Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pediatric Preventable Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pediatric Preventable Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pediatric Preventable Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pediatric Preventable Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Inc. Basic Information
Table 63. Pfizer Inc. Pediatric Preventable Vaccine Product Overview
Table 64. Pfizer Inc. Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Inc. Business Overview
Table 66. Pfizer Inc. SWOT Analysis
Table 67. Pfizer Inc. Recent Developments
Table 68. Merck and Co., Inc. Basic Information
Table 69. Merck and Co., Inc. Pediatric Preventable Vaccine Product Overview
Table 70. Merck and Co., Inc. Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck and Co., Inc. Business Overview
Table 72. Merck and Co., Inc. SWOT Analysis
Table 73. Merck and Co., Inc. Recent Developments
Table 74. GlaxoSmithKline plc (GSK) Basic Information
Table 75. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Overview
Table 76. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GlaxoSmithKline plc (GSK) Business Overview
Table 78. GlaxoSmithKline plc (GSK) SWOT Analysis
Table 79. GlaxoSmithKline plc (GSK) Recent Developments
Table 80. Sanofi Pasteur Basic Information
Table 81. Sanofi Pasteur Pediatric Preventable Vaccine Product Overview
Table 82. Sanofi Pasteur Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Pasteur Business Overview
Table 84. Sanofi Pasteur Recent Developments
Table 85. Moderna, Inc. Basic Information
Table 86. Moderna, Inc. Pediatric Preventable Vaccine Product Overview
Table 87. Moderna, Inc. Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Moderna, Inc. Business Overview
Table 89. Moderna, Inc. Recent Developments
Table 90. Serum Institute of India Pvt. Basic Information
Table 91. Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Overview
Table 92. Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Serum Institute of India Pvt. Business Overview
Table 94. Serum Institute of India Pvt. Recent Developments
Table 95. Bharat Biotech International Basic Information
Table 96. Bharat Biotech International Pediatric Preventable Vaccine Product Overview
Table 97. Bharat Biotech International Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bharat Biotech International Business Overview
Table 99. Bharat Biotech International Recent Developments
Table 100. CSL Limited (Seqirus) Basic Information
Table 101. CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Overview
Table 102. CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. CSL Limited (Seqirus) Business Overview
Table 104. CSL Limited (Seqirus) Recent Developments
Table 105. Emergent BioSolutions Inc. Basic Information
Table 106. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Overview
Table 107. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Emergent BioSolutions Inc. Business Overview
Table 109. Emergent BioSolutions Inc. Recent Developments
Table 110. Daiichi Sankyo Company Basic Information
Table 111. Daiichi Sankyo Company Pediatric Preventable Vaccine Product Overview
Table 112. Daiichi Sankyo Company Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Daiichi Sankyo Company Business Overview
Table 114. Daiichi Sankyo Company Recent Developments
Table 115. Novavax, Inc. Basic Information
Table 116. Novavax, Inc. Pediatric Preventable Vaccine Product Overview
Table 117. Novavax, Inc. Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Novavax, Inc. Business Overview
Table 119. Novavax, Inc. Recent Developments
Table 120. Sinovac Biotech Basic Information
Table 121. Sinovac Biotech Pediatric Preventable Vaccine Product Overview
Table 122. Sinovac Biotech Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Sinovac Biotech Business Overview
Table 124. Sinovac Biotech Recent Developments
Table 125. Sinopharm Group Co., Basic Information
Table 126. Sinopharm Group Co., Pediatric Preventable Vaccine Product Overview
Table 127. Sinopharm Group Co., Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Sinopharm Group Co., Business Overview
Table 129. Sinopharm Group Co., Recent Developments
Table 130. Johnson and Johnson (Janssen) Basic Information
Table 131. Johnson and Johnson (Janssen) Pediatric Preventable Vaccine Product Overview
Table 132. Johnson and Johnson (Janssen) Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Johnson and Johnson (Janssen) Business Overview
Table 134. Johnson and Johnson (Janssen) Recent Developments
Table 135. AstraZeneca plc Basic Information
Table 136. AstraZeneca plc Pediatric Preventable Vaccine Product Overview
Table 137. AstraZeneca plc Pediatric Preventable Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. AstraZeneca plc Business Overview
Table 139. AstraZeneca plc Recent Developments
Table 140. Global Pediatric Preventable Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Pediatric Preventable Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Pediatric Preventable Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Pediatric Preventable Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Pediatric Preventable Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Pediatric Preventable Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Pediatric Preventable Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Pediatric Preventable Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Pediatric Preventable Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Pediatric Preventable Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Pediatric Preventable Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Pediatric Preventable Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Pediatric Preventable Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Pediatric Preventable Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Pediatric Preventable Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Pediatric Preventable Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Pediatric Preventable Vaccine Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Pediatric Preventable Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pediatric Preventable Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Pediatric Preventable Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Pediatric Preventable Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pediatric Preventable Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pediatric Preventable Vaccine Product Life Cycle
Figure 13. Pediatric Preventable Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Pediatric Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pediatric Preventable Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pediatric Preventable Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Pediatric Preventable Vaccine
Figure 19. Global Pediatric Preventable Vaccine Market PEST Analysis
Figure 20. Global Pediatric Preventable Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pediatric Preventable Vaccine Market Share by Type
Figure 27. Sales Market Share of Pediatric Preventable Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pediatric Preventable Vaccine by Type in 2025
Figure 29. Market Share of Pediatric Preventable Vaccine by Type (2020-2025)
Figure 30. Market Share of Pediatric Preventable Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pediatric Preventable Vaccine Market Share by Application
Figure 33. Global Pediatric Preventable Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pediatric Preventable Vaccine Sales Market Share by Application in 2025
Figure 35. Global Pediatric Preventable Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pediatric Preventable Vaccine Market Share by Application in 2025
Figure 37. Global Pediatric Preventable Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pediatric Preventable Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pediatric Preventable Vaccine Market Size by Region (2020-2025)
Figure 40. North America Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pediatric Preventable Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pediatric Preventable Vaccine Market Size by Country in 2024
Figure 45. U.S. Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pediatric Preventable Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pediatric Preventable Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pediatric Preventable Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pediatric Preventable Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pediatric Preventable Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pediatric Preventable Vaccine Market Size by Country in 2024
Figure 55. Germany Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pediatric Preventable Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pediatric Preventable Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pediatric Preventable Vaccine Market Size by Region in 2024
Figure 68. China Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pediatric Preventable Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pediatric Preventable Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pediatric Preventable Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pediatric Preventable Vaccine Market Size by Country in 2024
Figure 82. Brazil Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pediatric Preventable Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pediatric Preventable Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pediatric Preventable Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pediatric Preventable Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pediatric Preventable Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pediatric Preventable Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pediatric Preventable Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pediatric Preventable Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pediatric Preventable Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pediatric Preventable Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pediatric Preventable Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pediatric Preventable Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pediatric Preventable Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pediatric Preventable Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pediatric Preventable Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Pediatric Preventable Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Pediatric Preventable Vaccine Market Share Forecast by Application (2026-2035)